mHealthEPSA Annual Reception 2014Edwin Maarseveen, DG SANCO, European Commission

"Mercom Capital Group, a consulting firm, reckons that of the $2.2 billion venture capitalists put into health-care startups last year, $564m went to m-health businesses."

The Economist, 2014

‼ Privacy issues‼ Health inequalities‼ Disruptive economic effects‼ Legal uncertainty‼ Quality assurance‼ Cross-border‼ ……

mHealth – Risks

mHealth – potential

+Efficiency, sustainability, saving costs+Easier Access+Better Information+Evidence-based and personalised

treatment+Economic possibility industry+……

mHealth – part of HC transition

Patient involvement/empowerment More support from data and transparency More personalised Health care not a 'stand-alone' sector Less linked to property

• The Green Paper on mHealth will launch a debate among stakeholders on what should be done at EU level to release the potential of mHealth in Europe.

• It will be accompanied by a SWD explaining the legal framework applicable to health and wellbeing apps

→Due to be published during Q1 2014

PURPOSE OF THE GREEN PAPER ON M-HEALTH

mHealth – personal statement

1. Mobile will develop fast: HC should use it

2. mHealth similar to health systems transition

3. Biggest thing about mHealth = Big Data